Medicamen Organics Ltd
NSE: MEDIORG
₹24.40
₹-1.25
(-4.87%)
As on 11-Aug-2026 14:18IST
Market cap
₹31 Cr
Revenue (TTM)
₹38 Cr
P/E Ratio
--
P/B Ratio
1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹4 Cr
-
ROE
18.1 %
-
ROCE
17 %
-
Industry P/E
39.17
-
EV/EBITDA
-10.7
-
Debt to Equity
0.4
-
Book Value
₹25.1
-
EPS
₹3.5
-
Face value
10
-
Shares outstanding
12,165,910
5 Years Aggregate
CFO
₹-9.92 Cr
EBITDA
₹16.05 Cr
Net Profit
₹8.04 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Medicamen Organics
| 1.7 | 9.7 | -15.9 | -28.3 | -- | -- | -- |
|
BSE Healthcare
| 18.2 | 2.8 | 10.4 | 19.0 | 22.0 | 14.3 | 12.4 |
|
Company
|
2025
|
|---|---|
|
Medicamen Organics
| -55.1 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Medicamen Organics
|
24.4 | 31.2 | 38.2 | 4.1 | -- | 18.1 | -- | 1.0 |
| 1,399.8 | 16,865.7 | 2,590.4 | 603.0 | 29.3 | 19.6 | 28 | 4.8 | |
| 588.6 | 11,213.6 | 885.7 | 234.9 | 27.8 | 18 | 47.7 | 5.0 | |
| 1,431.7 | 14,823.6 | 1,108.4 | 270.2 | 28.3 | 14.5 | 53.8 | 7.1 | |
| 1,995.2 | 37,879.1 | 9,683.5 | 1,019.0 | 15.7 | 21.3 | 37.5 | 7.2 | |
| 22,814.0 | 28,474.3 | 2,371.8 | 497.8 | 28.0 | 28.5 | 57.2 | 14.1 | |
| 1,080.8 | 6,447.2 | 811.3 | 21.0 | 0.7 | 2.1 | 313.8 | 5.0 | |
| 1,469.0 | 6,548.8 | 691.7 | 130.8 | 24.5 | 14.5 | 51.8 | 6.8 | |
| 1,105.8 | 11,903.1 | 675.6 | 183.6 | 32.2 | 22.7 | 65.2 | 12.9 | |
| 342.3 | 9,403.7 | 8.8 | -352.4 | -4,228.0 | -80.8 | -- | 16.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Medicamen Organics
--
-
Incorporated
1995
-
Chairman
--
-
Managing Director
Bal Kishan Gupta
-
Headquarters
New Delhi, Delhi
-
Website
Looking for more details about Medicamen Organics Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Medicamen Organics
What is the current share price of Medicamen Organics Ltd Today?
The share price of Medicamen Organics Ltd is ₹24.40 (NSE) as of 11-Aug-2026 14:18 IST. Medicamen Organics Ltd has given a return of -28.34% in the last 1 years.
What is the current PB & PE ratio of Medicamen Organics Ltd?
Since, TTM earnings of Medicamen Organics Ltd is negative, P/E ratio is not available.
The P/B ratio of Medicamen Organics Ltd is 0.96 times as on 07-Aug-2026, a 73 discount to its peers’ median range of 3.61 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
6.27
|
0.86
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Medicamen Organics Ltd?
The 52-week high and low of Medicamen Organics Ltd are Rs 41.00 and Rs 19.10 as of 11-Aug-2026.
What is the market cap of Medicamen Organics Ltd?
Medicamen Organics Ltd has a market capitalisation of ₹ 31 Cr as on 07-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Medicamen Organics Ltd?
Before investing in Medicamen Organics Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.